Adamax – the technical answer

Adamax: Overview – The More Technical Answer

Adamax is a synthetic, modified research peptide derived from Semax. It incorporates an adamantane group intended to improve metabolic stability, increase lipophilicity, and potentially enhance penetration across the blood-brain barrier.

What Is Adamax?

Adamax is a modified analog of Semax, a heptapeptide derived from the ACTH 4–10 fragment. Its structure incorporates an N-terminal modification along with a C-terminal adamantane group associated with the design of P21.

The addition of the adamantane moiety increases the molecule’s lipid solubility and may make it more resistant to enzymatic degradation. These modifications are intended to influence the compound’s stability and distribution within the body.

Proposed Mechanisms Under Investigation

Adamax is studied primarily in preclinical and laboratory research to investigate its potential interactions with neurological pathways, including:

• BDNF Expression: Research has explored whether Adamax may influence the expression of brain-derived neurotrophic factor (BDNF), a protein involved in neuronal growth, maintenance, and plasticity.
• TrkB Receptor Signaling: Preclinical research investigates potential effects on TrkB receptors, which are activated by BDNF and play an important role in neuronal signaling and plasticity.
• Neuroplasticity and Cognition: Researchers are investigating whether these mechanisms could influence processes associated with neuroplasticity, memory formation, learning, and attention.